Dr. Tiwari focuses on understanding the virulence mechanisms utilized by pathogens and the immune mechanisms of the host against pathogens using mice and human cell models. Her research involves the utilization of this gained knowledge to develop novel chemotherapies and vaccines against these pathogens.

• U-RISE fellowship to Jordan R Watson (01/27/2024)
• Invited Grant Reviewer for NIH (NIAID) Special Emphasis Panel (ZAI1 SAS-W(J1) - NIH (11/30/2023)
• Invited Grant Reviewer for study section: Broad Agency Announcement (BAA): Large-scale T cell Immune Epitope Discovery and Mechanisms of T cell Protection - NIH (10/25/2023)
• Invited Grant Reviewer for Special Emphasis Panel (ZRG1 DCAI- D(10)) Small Business: Applied Immunology and Vaccine Development study section - NIH (06/21/2023)
• Selected as UTEP Ambassador for "All Of Us program" sponsored by Baylor College of Medicine - Baylor College of Medicine (06/01/2023)
• ASM Rio Grande Branch Officer (Treasurer) (05/01/2023)
• LSAMP Summer fellowship to Alberto A Barraza Flores (05/01/2023)
• Invited Grant Reviewer for NIH (NIAID) special Emphasis Panel ( ZAI1 HPW-D (M1) - NIH (03/10/2023)
• Project Initiation Seed Award : Identification and Validation of SNPs as Risk Factors for IBD - Baylor College of Medicine (01/13/2023)
• Associate Editor for Frontiers in Cellular and infection Microbiology: Adaptive immunity in infection - Frontiers (10/01/2022-10/31/2022)
• Editor for Journal "Tropical Medicine and Infectious Disease" - MDPI (10/01/2022-10/31/2022)
• Seed Award : Identification of SNPs as Risk Factors for IBD - Baylor College of Medicine (10/14/2022)
• Grant Reviewer for NIH/HCAC study section - NIH (07/21/2022)
• UBR Scholars Program selection - Baylor College of Medicine (05/18/2022)
• Grant Reviewer for NIAID for Sure-First - NIH (02/25/2022)
• Guest Associate Editor in Frontiers in Immunology:Molecular Innate Immunity - University of Texas at El Paso (12/10/2021)
• Guest Associate Editor in Frontiers in Microbiology:in Evolutionary and Genomic Microbiology - University of Texas at El Paso (12/10/2021)
• Grant Reviewer in NIAID grant Review Panel for Sure-First - NIAID (12/01/2021)
• Internal Grant Selection for Johnson & Johnson - WiSTEM2D Scholars Program - Johnson & Johnson - WiSTEM2D Scholars Program (09/13/2021)
• Grant Internally selected for submission to Mallinckrodt Foundation - Mallinckrodt Foundation (07/01/2021)
• R15:A NOVEL QUADRUPLE KNOCKOUT MTB VACCINE AGAINST TUBERCULOSIS - NIH (06/08/2021)
• Selected for Early Career Reviewer (ECR) Program_HCAC - NIH (05/18/2021)
• Review Editor for Frontiers in Cellular and Infection Microbiology: Molecular bacterial Pathogenesis - Frontiers in Cellular and Infection Microbiology (05/08/2021)
• Bridges Year-long fellowship to Diya A. Vanmali- Bridges to the baccalaureate May 1, 2021 - UTEP (05/01/2021)
• SC1 grant : DEVELOPMENT OF DRUGS TO TARGET ARGININE BIOSYTHESIS IN MYCOBACTERIUM TUBERCULOSIS - NIH (04/22/2021)
• Grant Internally selected for submission to Johnson and Johnson_WiSTEM2D Scholars award, Selected in UTEP internal competition - 2020 J&J WiSTEM2D Scholars Award Program (09/03/2020)
• Bridges Year-long fellowship to Brandon Zavala- Bridges to the baccalaureate - utep (09/01/2020)
• BUILD Year-long fellowship to Luisa a. Dominguez - (07/1/2020) - utep (07/01/2020)
• Rising Star Award to Dr. Tiwari From University of Texas system - Universy of Texas (01/29/2020)

• Ph D in Microbiology & Biochemistry , Jawaharlal Nehru University/Institute of Microbial technology_CSIR (2005)
• BSEd in Education, Punjab University (1999)
• MS in Molecular Biology & Biochemistry, Guru Nanak Dev University (1998)

• Boosting bactericidal immunity of a recombinant Mycobacterium smegmatis strain via zinc-dependent ribosomal proteins. bioRxiv : the preprint server for biology (2023), S Singh, D Kanzin*, S Chavez*, N A. Saavedra-Avila, T W. Ng, R Lukose, O Mayer, J Kim, B Chen, M Chen, S A. Porcelli, W R. Jacobs, Sangeeta Tiwari.
• Rv0687 a Putative Short-Chain Dehydrogenase is indispensable for pathogenesis of Mycobacterium tuberculosis. bioRxiv : the preprint server for biology, in Review in Frontiers in Microbiology (2023), G Bhargavi*, M K. Mallakuntla*, D Kale*, Sangeeta Tiwari#.
• Linkage between membrane composition, cellular functions and membrane-mediated stress. Frontiers in genetics 14 (2023), P Saha, M C. Joshi, Sangeeta Tiwari, R Saxena.
• Different modalities of host cell death and their impact on Mycobacterium tuberculosis infection Am J Physiol Cell Physiol . 323 5 (2022), Annuurun Nisa, Franciele C. Kipper, Dipak Panigrahy, Sangeeta Tiwari, Andreas Kupz, Selvakumar Subbian.
• Implications of Fragment-Based Drug Discovery in Tuberculosis and HIV. Pharmaceuticals (Basel) (2022), Mohan . Mallakuntla*, Namdev S. Togre*, Destiny B. Santos*, Sangeeta Tiwari#.
• Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges. International journal of molecular sciences 23 18 (2022), N S. Togre*, A M. Vargas*, G Bhargavi*, M K. Mallakuntla*, Sangeeta Tiwari#.
• A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19. Frontiers in immunology 13 (2022), Satvir Singh, N A. Saavedra-Avila, Sangeeta Tiwari, S A. Porcelli.
• A fragment-based approach to assess the ligandability of ArgB, ArgC, ArgD and ArgF in the L-arginine biosynthetic pathway of Mycobacterium tuberculosis COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL 19 (2021), Pooja Gupta, Sherine E. Thomas, Shaymaa A. Zaidan*, Maria A. Pasillas*, James Cory-Wright, Ailidh Burgess, Victor Sebastian-Perez, Emma Cattermole, Clio Meghir, Chris Abell, Anthony G. Coyne, William R. Jacobs, Tom L. Blundell, Vitor Mendes #, Sangeeta Tiwari #.
• A Novel “Eccentric” Therapeutic Approach for Individuals Recovering From COVID-19 Cardiopulmonary Physical Therapy Journal Publish Ahead of Print (2021), Alvaro Gurovich, Sangeeta Tiwari, Stephanie Kehl, Emre Umucu, Luis Peñailillo.
• A Novel “Eccentric” Therapeutic Approach for Individuals Recovering From COVID-19 Cardiopulmonary Physical Therapy Journal. (2020), Alvaro Gurovich, Sangeeta Tiwari, Stephanie Kehl*, Emre Umucu, Luis Peñailillo.
• BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosis VACCINE 38 45 (2020), Sangeeta Tiwari #, Taru S. Dutt, Bing Chen, Mei Chen, John Kim, Annie Z. Dai, Regy Lukose, Crystal Shanley, Amy Fox, Burton R. Karger, Steven A. Porcelli, John Chan, Brendan K. Podell, Andres Obregon-Henao, Ian M. Orme, Jacobs, William R., Jr.#, Marcela Henao-Tamayo #.
• Infect and Inject: How Mycobacterium tuberculosis Exploits Its Major Virulence-Associated Type VII Secretion System, ESX-1 ASM Journal 7 3 (2019), Sangeeta Tiwari +#, Rosalyn Casey, Celia W Goulding, Suzie Hingley-Wilson , William R Jacobs Jr #.

• Rare Genetic Variants Are Candidates for Driving Inflammatory Bowel Disease (IBD) in Ethnic populations (2023), Volume BSRB, UTEP, Sangeeta Tiwari.
• Identification and Validation of SNPs as Risk Factors for IBD in the All of Us Database (2023), Volume online, Sangeeta Tiwari.
• Sterilizing Mycobacterium tuberculosis: De novo Arginine biosynthesis pathway as a novel drug target (2023), Volume Barcelona, spain, Sangeeta Tiwari.
• Targeting Achilles heel of Mycobacterium tuberculosis to accelerate TB drug discovery (2023), Volume Online, Sangeeta Tiwari.
• Challenges in finding Achille’s heel to sterilize Mycobacterium tuberculosis (2023), Volume UTEP, Sangeeta Tiwari.
• Mapping the mechanisms of action between pathogenic Mycobacterium fortuitum and its interaction with the brain’s resident macrophages in the central nervous system (2023), Volume UTEP, Ana M. Vargas, Sangeeta Tiwari.
• Opening the Pandora box: ESX-5, a Type VII secretion system of Mycobacterium tuberculosis (2023), Volume UTEP, Mohan Krishna Mallakuntla, Sangeeta Tiwari.
• Role of ESX-5 effector in pathogenesis and transmission of Mycobacterium tuberculosis (2023), Volume UTEP, Eduardo Ibbara, Sangeeta Tiwari.
• Role of ESX-5 effector in Pathogenesis and Transmission of Mycobacterium tuberculosis (2023), Volume UTEP, Yoome Han, Eduardo Ibarra, Mohankrishna Mallakuntla, Sangeeta Tiwari.
• Functional characterization of putative ferredoxin reductase Rv0688 of Mycobacterium tuberculosis (2023), Volume UTEP, Gunapati Bhargavi, Sangeeta Tiwari.
• Role of ESX-5 effectors in Pathogenesis and Transmission of Mycobacterium tuberculosis (2023), Volume UTEP, Eduardo M. Ibbara, Laura V. Ochoa, Yoome Han, Ninoshka Pachot, Mohan Krishna Mallakuntla , Sangeeta Tiwari.
• Sterilizing Mycobacterium tuberculosis: Why it’s so challenging? (2023), Volume Texas Biomedical Research Institute, San Antonio, Sangeeta Tiwari.
• Rare Genetic Variants Are Candidates for Driving Inflammatory Bowel Disease (IBD) in Ethnic populations (2023), Volume Houston, Sangeeta Tiwari.
• De novo Arginine biosynthesis pathway: A novel drug target for sterilization of Mycobacterium tuberculosis (2022), Gunapati Bhargavi, Ana M. Vargas, Sangeeta Tiwari.
• Sterilizing Mycobacterium tuberculosis: Why it’s so challenging? (2022), Volume Breckenridge, CO, USA, Sangeeta Tiwari.
• Identification of SNPs as Risk Factors for IBD in the All of Us Database (2022), Volume Houston, Sangeeta Tiwari.
• De novo Arginine biosynthesis pathway as a novel drug target for sterilization of Mycobacterium tuberculosis (2022), Volume El Paso, Sangeeta Tiwari.
• De novo Arginine biosynthesis pathway as a novel drug target for sterilization of Mycobacterium tuberculosis (2022), Volume EL Paso, Abraham V. Mundo, Ana M. Vargas, Azul Gomez, Sangeeta Tiwari.
• Host Pathogen Interaction (2022), Volume UTEP, Sangeeta Tiwari.
• NRMN success story of Sangeeta Tiwari (2021), Volume webinar, Sangeeta Tiwari.
• Bladder Cancer Immunotherapy (2021), Sangeeta Tiwari.
• My Journey to Research and Teaching (2021), Volume UTEP, Sangeeta Tiwari.
• Live attenuated Mtb Vaccines (2021), Volume online, Sangeeta Tiwari.
• Chemotherapies and Vaccines (2021), Sangeeta Tiwari.
• Understanding Immune evasion mechanisms of Pathogens for Vaccine Design (2021), Volume UTEP, Sangeeta Tiwari.
• Novel live attenuated vaccine candidate for Tuberculosis (2020), Volume Online, Sangeeta Tiwari.
• Chemotherapies and Vaccines against tuberculosis (2020), Volume El Paso, Sangeeta Tiwari.
• Drug Targeting of De novo arginine biosynthesis pathway for treatment of Tuberculosis (2020), Volume India , Sangeeta Tiwari.
• live attenuated Mtb based vaccines for Tuberculosis (2020), Volume webinar, Sangeeta Tiwari.
• Novel mycobacterial virulence factors and evasion of host immunity in tuberculosis (2019), Volume San Francisco, Sangeeta Tiwari.
• Trargeting arginine biosynthesis leads to in vivo sterilization of Mycobacterium tuberculosis (2019), Volume Banff, Canada, Sangeeta Tiwari.

• Project Initiation Seed Award : Identification and Validation of SNPs as Risk Factors for IBD
• R15: A NOVEL QUADRUPLE KNOCKOUT MTB VACCINE AGAINST TUBERCULOSIS
• SC1: DEVELOPMENT OF DRUGS TO TARGET ARGININE BIOSYTHESIS IN MYCOBACTERIUM TUBERCULOSIS
• University of Texas: RISING STAR AWARD